Figure 7.
Relationships between Immune Landscape and Clinical Outcomes
(A) The first two components of correspondence analysis, accounting for 30% of the co-association structure between immune subsets and patients in the cohort, are shown. Immune phenotypes are displayed as squares (TAMs) and triangles (T cells), and patient samples as circles.
(B) Contributions of the immune subsets to CA-1 and CA-2.
(C) Projection of each patient onto the first and second component of the correspondence analysis. Circle size represents progression-free survival time. CA-2 assigns high scores (right of dotted line and labeled in blue) to six patients with low progression-free survival times.
(D) Kaplan-Meier analysis of the six patients with low progression-free survival times (blue curve) versus the remaining patients (green curve). Shaded regions represent 95% confidence intervals.